WebMyopathy, including rhabdomyolysis, is a well-known, albeit rare complication of statin therapy. Predisposing factors include comorbidities and the concomitant use of cytochrome P-450 (CYP) 3A4 inhibitors. We report a case of severe simvastatin-induced rhabdomyolysis triggered by the addition of amiodarone to previously well-tolerated chronic ... Webmyopathy, including rhabdomyolysis, was highest during the first year and then notably decreased during the subsequent years of treatment. In this trial, patients were carefully …
Drug-induced myopathies - UpToDate
WebMay 27, 2024 · The majority of the complaints include nonspecific benign symptoms, and 7–25% will develop a documented muscle event. 4,8-10 These include myalgia, myopathy, myositis (including INMN), myonecrosis or rhabdomyolysis. 11 While all events could co-exist, it is important to establish a non-ambiguous terminology and note the differences, … WebPatients should be advised of the increased risk of myopathy, including rhabdomyolysis, with the 10/80-mg dose. (5.1) •Patients should be advised to report promptly any unexplained and/or persistent muscle pain, tenderness, or weakness. VYTORIN should be discontinued immediately if myopathy is diagnosed or suspected. (5.1) free jumbo word search printable puzzles
Imatinib as a Possible Cause of Severe Rhabdomyolysis NEJM
WebRhabdomyolysis is a fulminant and acute, necrotizing myopathy that can cause severe pain, muscle swelling and weakness, and elevated serum CK as high as 2000 times the upper limit of normal. It is associated with myoglobinuria (urine that appears dark brown or pink due to the presence of pigmented myoglobin), which can cause acute renal failure ... WebSevere myopathy, including rhabdomyolysis with acute renal failure secondary to myoglobinuria, has been reported rarely with the use of HMG-CoA reductase inhibitors. The myopathy may be dose-related and is characterized by muscle aches and/or weakness in conjunction with increases in creatine phosphokinase (CPK) values exceeding 10 times … WebThe majority of the complaints include nonspecific benign symptoms, and 7–25% will develop a documented muscle event. 4,8-10 These include myalgia, myopathy, myositis (including INMN), myonecrosis or rhabdomyolysis. 11 While all events could co-exist, it is important to establish a non-ambiguous terminology and note the differences, as the ... blue cross blue shield sc preferred drug list